PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-55.65%
Both yoy net incomes decline, with CNQ at -63.72%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
2.44%
Less D&A growth vs. CNQ's 42.19%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-72.15%
Negative yoy deferred tax while CNQ stands at 112.96%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
105.88%
SBC growth well above CNQ's 200.00%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-172.73%
Both reduce yoy usage, with CNQ at -230.00%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
207.02%
AR growth of 207.02% while CNQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-172.73%
Both reduce yoy usage, with CNQ at -230.00%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
29.17%
Some yoy increase while CNQ is negative at -156.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-16.56%
Both yoy CFO lines are negative, with CNQ at -11.99%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
24.53%
Some CapEx rise while CNQ is negative at -8.07%. John Neff would see competitor possibly building capacity while we hold back expansions.
1073.33%
Acquisition spending well above CNQ's 100.00%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-373.33%
Negative yoy purchasing while CNQ stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
-373.33%
We reduce yoy other investing while CNQ is 95.05%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
29.31%
Lower net investing outflow yoy vs. CNQ's 79.66%, preserving short-term cash. David Dodd would confirm expansions remain sufficient.
91.75%
We repay more while CNQ is negative at -12.28%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
66.56%
Repurchase growth 1.25-1.5x CNQ's 56.78%. Bruce Berkowitz would confirm if the firm invests enough in expansions while boosting EPS.